Different forms of glucose-6-phosphate dehydrogenase (G-6-PD) have been described in different tissues. Moreover, the directly determined amino acid sequence amino end of the red cell enzyme does not exactly match the sequence deduced from cDNA isolated from HeLa cells or lymphoblasts. We have therefore investigated the sequence of cDNA from sperm, granulocytes, reticulocytes, brain, placenta, liver, lymphoblastoid cells, and cultured fibroblasts.
Introduction
Recently the structure of human glucose-6-phosphate dehydrogenase (G6PD'; D-glucose-6-phosphate: NADP+ oxidoreductase, EC 1.1.1 49) has been extensively elucidated. The complete amino acid sequence (1) , nucleotide sequence of cDNA (1, 2) and partial genomic DNA sequence (3) have already been published. Very recently single base substitutions have been disclosed in several G6PD variants (4) (5) (6) .
Although G6PD is a single copy X-linked gene, some variability of the enzyme in various tissues has been noted. A G6PD isozyme has been described in human fetal brain (7) and some microheterogeneity has been noted in other tissues (8, 9) . Such differences have generally been ascribed to posttranslational modification of the enzyme. However, recent study of G6PD cDNA by molecular cloning has suggested the existence of multiple forms of human G6PD mRNA that may produce multiple forms of enzyme protein. We isolated two different forms of G6PD cDNA from human EBV-transformed lymphoblastoid cells (5) . Moreover, discrepancies between the amino acid sequences of the amino end of normal red cell G6PD determined directly from peptides (1) and that deduced from the nucleotide sequence (2) might suggest the existence of further different forms ofG6PD in the human red cell. These different forms of G6PD appear to be generated by the alternative splicing of the same gene transcript (5) .
Recent development of a DNA amplification technique using the polymerase chain reaction (PCR) (10) has made it possible to detect different forms of mRNA with great sensitivity. We present the evidence that previously described two different forms of cDNA (5) Preparation ofpoly(A)+RNA and cDNA synthesis. Granulocytes and sperm were obtained from a normal male. Granulocytes were purified by 2% dextran-saline sedimentation combined with Ficoll barrier gravity sedimentation. Reticulocytes were obtained from a female patient with hemolytic anemia whose peripheral reticulocyte count was 23%. Whole blood was purified by filtration through an a-cellulose-microcrystalline cellulose column (13) . Contamination by leukocytes in the final preparation was estimated as 1-14,000 reticulocytes. Total RNA was extracted by the guanidine thiocyanate method (14) and poly(A)+RNA was prepared by oligo(dT)-cellulose column chromatography (15) . First and second cDNA strand synthesis was carried out by the method of Lapeyre and Amalric (16) . A synthetic 17-mer oligonucleotide (Primer 8 or 10) corresponding to a unique sequence in G6PD cDNA was used as the primer (Table I) .
DNA amplification. The first-strand cDNA synthesized from mRNA, double-stranded cDNA in libraries, and genomic DNA containing the target sequence were amplified by PCR (10), with Taq Table I . To determine the nucleotide sequence of reticulocyte G6PD cDNA, 100 ng of blunt-ended, double-stranded cDNA were circularized intramolecularly before PCR by incubating at 4VC for 14 h with 800 U of T4 DNA ligase in 10 ,g of 50 mM Tris-HCI (pH 8.0), 7 mM MgCl2, 1 mM dithiothreitol, and 0.5 mM ATP. The amplified DNA segments were separated by 5 or 8% polyacrylamide gel electrophoresis and visualized by ethidium bromide or silver stain (19) . For nucleotide sequencing, amplified DNA was removed from the gel and sequenced by the chemical cleavage method (20) and/or the dideoxynucleotide chain terminating method (21) with slight modification (22) .
Results
Nucleotide sequence ofintron 7. The entire sequence of intron 7 from genomic DNA of G6PD B(+) and G6PD A(-) males was amplified using primers 9 and 10 ( Table I ). The amplified 463bp-segments were separated by 5% PAGE and sequenced ( Fig. 1) . Except for the 174th base, which was T in G6PD A(-), the nucleotide sequences of both amplified DNAs were identical and consistent with the published partial sequence (3). The 138 bases in the 3'-end of intron 7 were identical to the extra sequence found in a G6PD A(-) cDNA clone A-7 (5 Tissue distribution ofdifferent forms of G6PD mRNA. To examine the tissue distribution ofthe different forms ofG6PD mRNA, corresponding DNA sequence was amplified by PCR using primers 9 and 10 from first-stranded cDNA prepared from granulocytes, reticulocytes, normal lymphoblastoid cells and sperm or double-stranded cDNA in cDNA libraries from liver, placenta, fibroblasts, and lymphoblastoid cells. Each amplified segment was separated by 8% polyacrylamide gel electrophoresis (Fig. 2) . As summarized in Table II , in all the tissues examined a 99-bp fragment derived from normal splicing was dominant. Additional 237-bp fragments derived from a different splicing were detected only in samples from granulocytes, sperm, and lymphoblastoid cells. The 237-bp band of normal lymphoblastoid cell sample was very faint. Approximation by densitometry showed that the content ofthe 237-bp splicing product represented < 3% of the 99-bp splicing product.
Structure ofthe coding region ofreticulocyte G6PD cDNA. To examine the existence of different forms of mRNA in human reticulocytes, cDNA corresponding to the 5'-halfofthe coding sequence was synthesized using 5'-phosphorylated primer 8 and circularized by T4 DNA ligase (see Methods).
Under these conditions some concatemers should have been formed as well as circular forms. Fig. 3 shows the location of sequences corresponding to each primer. The target DNA sequence was first amplified using primers 6 and 7. The length of amplified segments ranged from 40 to 1,500 bp (data not shown). The fragments of 800-1,000 bp, which might contain enough long target sequence, were removed from a gel and used as templates for re-amplification using 5'-labeled primer 4 and unlabeled primer 7. Amplified DNA was separated by 5% PAGE and well-isolated bands on the autoradiogram were removed from the gel. The sequencing of these 5'-labeled DNAs by the method ofMaxam and Gilbert (20) revealed that several amplified DNA contained entire coding sequence 5' to the site of primer 4 known to generate multiple forms of protein using alternative splicing (24) . Previously we reported a G6PD cDNA clone that has extra 138 bases coding 46 amino acids (5) . In the present study we confirmed that this extra coding sequence was derived from intron 7 of G6PD gene and was preceded by a 3'-AG acceptor with a consensus splicing sequence (23) . These findings strongly suggest that two types of mRNA with different coding sequences were generated by an alternative splicing of the 7th intron of the G6PD gene.
Although the longer form of G6PD cDNA clone was first found in a cDNA library from a Black male with G6PD A(-), the present study of its tissue distribution revealed that this type of mRNA or cDNA was not specifically related to G6PD A(-) variant nor to lymphoblastoid cells. It was detected in granulocytes and sperm as well as lymphoblastoid cells. Persico et al. (2) performed Northern blot analysis for G6PD mRNA from various tissues and reported the existence of only single species of G6PD mRNA. However, the extremely low content of the longer form mRNA might not allow it to be detected by conventional technique other than the DNA amplification by PCR.
The mRNA with extra coding sequence should generate an enzyme protein with 561 amino acids whose molecular weight is -9% higher than the common G6PD monomer. Although this difference in molecular weight might make it possible to separate these two types ofG6PD protein by SDS-PAGE, there has so far been no report ofdetecting the longer form ofG6PD protein. We have carried out SDS-PAGE of leucocyte G6PD followed by immunoblotting analysis. However, only the common form of G6PD was detected (unpublished observation). What is the function of the longer form G6PD? Considering the very low content of the mRNA, it might rather be regarded as a nonfunctional remnant of cell differentiation process than an active functioning enzyme even if it is translated normally. According to the PEST hypothesis proposed by Rogers et al. (25) , the amino acid sequence of proteins with short intracellular half-lives contain one or more regions rich in proline, glutamic acid, serine, and threonine (PEST region). The serine rich region in the extra portion of the long G6PD (4th Arg to 25th His in Fig. 1 ) appears to be compatible with the PEST region. It is well known that in some tissues the switching of isozyme pattern occurs during maturation or malignant transformation ofcells (26, 27) . It is possible that similar switching ofG6PD isozyme occurs in some tissues, and the longer G6PD is the more unstable form dominant in immature cells.
The discrepancy between the amino acid sequence in amino end of human red cell G6PD protein (1) and that deduced from cDNA sequence (2, 5) is an unsolved puzzle. Since the nucleotide sequence was determined by using cDNA from tissues other than erythroid cells, it seemed possible that a different form of G6PD mRNA existed in those cells. The existence of a red cell-specific G6PD is reasonable considering the unique feature of red cell metabolism. One possible mechanism of generating these different mRNA might be an alternative splicing of exon 2 in G6PD. We obtained amplified DNA segments corresponding to exon 2 using the PCR technique and revealed that the nucleotide sequence was identical to those of other tissue G6PD cDNA. This may suggest that at least at the reticulocyte stage mRNA for a red cell specific G6PD is not a product of alternative splicing of exon 2.
